Article info
PDFOriginal research
Nasal fentanyl and buccal midazolam carer administration ‘as needed’ for breakthrough symptom control in a specialist palliative care unit: a nested qualitative study
- Correspondence to Dr Paul Perkins, Leckhampton Court Hospice, Cheltenham GL53 0QJ, UK; paul.perkins{at}suerydercare.org
Citation
Nasal fentanyl and buccal midazolam carer administration ‘as needed’ for breakthrough symptom control in a specialist palliative care unit: a nested qualitative study
Publication history
- Received October 15, 2020
- Revision received February 20, 2021
- Accepted March 11, 2021
- First published March 25, 2021.
Online issue publication
April 12, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.